Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susanne Andrea Gatz"'
Autor:
Andrea Ferrari, Susanne Andrea Gatz, Veronique Minard-Colin, Rita Alaggio, Shushan Hovsepyan, Daniel Orbach, Patrizia Gasparini, Anne-Sophie Defachelles, Michela Casanova, Giuseppe Maria Milano, Julia C. Chisholm, Meriel Jenney, Gianni Bisogno, Timothy Rogers, Henry C. Mandeville, Janet Shipley, Aisha B. Miah, Johannes H. M. Merks, Winette T. A. van der Graaf
Publikováno v:
Cancers, Vol 14, Iss 24, p 6060 (2022)
Rhabdomyosarcoma (RMS) is a typical tumour of childhood but can occur at any age. Several studies have reported that adolescent and young adult (AYA) patients with RMS have poorer survival than do younger patients. This review discusses the specific
Externí odkaz:
https://doaj.org/article/32f95e9b5cbe4bcf87f2d810e1cd48b8
Autor:
Shushan Hovsepyan, Claudia Giani, Sandro Pasquali, Angela Di Giannatale, Stefano Chiaravalli, Chiara Colombo, Daniel Orbach, Luca Bergamaschi, Sabina Vennarini, Susanne Andrea Gatz, Patrizia Gasparini, Pablo Berlanga, Michela Casanova, Andrea Ferrari
Publikováno v:
Expert Review of Anticancer Therapy. 23:471-484
Autor:
Andrea Ferrari, Bernadette Brennan, Michela Casanova, Nadege Corradini, Pablo Berlanga, Reineke A Schoot, Gema L Ramirez-Villar, Akmal Safwat, Gabriela Guillen Burrieza, Patrizia Dall'Igna, Rita Alaggio, Lisa Lyngsie Hjalgrim, Susanne Andrea Gatz, Daniel Orbach, Max M van Noesel
Publikováno v:
Ferrari, A, Brennan, B, Casanova, M, Corradini, N, Berlanga, P, Schoot, R A, Ramirez-Villar, G L, Safwat, A, Burrieza, G G, Dall’igna, P, Alaggio, R, Hjalgrim, L L, Gatz, S A, Orbach, D & van Noesel, M M 2022, ' Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas : Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) ', Cancer Management and Research, vol. 14, pp. 2885-2902 . https://doi.org/10.2147/CMAR.S368381
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) and the therapeutic recommendations developed by the European paediatric Soft tissue sarcoma Study Group (EpSSG). NRSTS form a very mixed gr
Autor:
Anne-Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H.M. Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie-Cécile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R. van Rijn, Véronique Minard-Colin, Julia C. Chisholm
Publikováno v:
Defachelles, A-S, Bogart, E, Casanova, M, Merks, J H M, Bisogno, G, Calareso, G, Melcon, S G, Gatz, S A, le Deley, M-C, McHugh, K, Probst, A, Rocourt, N, van Rijn, R R, Minard-Colin, V & Chisholm, J C 2022, ' Reply to H. B et al ', Journal of Clinical Oncology, vol. 40, no. 9, pp. 1030-1031 . https://doi.org/10.1200/JCO.21.02612
Journal of Clinical Oncology, 40(9), 1030-1031. American Society of Clinical Oncology
Journal of clinical oncology, 40(9), 1030-1031. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(9), 1030-1031. American Society of Clinical Oncology
Journal of clinical oncology, 40(9), 1030-1031. American Society of Clinical Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be2aa9596315bf3b8dc7777e46bfe5f
https://research.vumc.nl/en/publications/8f82ff4a-6898-4ba4-98de-45679139f9a0
https://research.vumc.nl/en/publications/8f82ff4a-6898-4ba4-98de-45679139f9a0
Autor:
Susanne Andrea Gatz, Marlen Keimling, Cindy Baumann, Thilo Dörk, Klaus-Michael Debatin, Simone Fulda, Lisa Wiesmüller
Publikováno v:
Carcinogenesis; Mar2008, Vol. 29 Issue 3, p519-519, 1p
Autor:
Defachelles AS; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Bogart E; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Casanova M; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Merks JHM; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Bisogno G; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Calareso G; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Melcon SG; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Gatz SA; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Le Deley MC; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., McHugh K; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Probst A; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Rocourt N; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., van Rijn RR; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Minard-Colin V; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Chisholm JC; Anne-Sophie Defachelles, MD, and Emilie Bogart, MD, Centre Oscar Lambret, Lille, France; Michela Casanova, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Johannes H.M. Merks, MD, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Gianni Bisogno, MD, PhD, Department of Women and Children Health, University Hospital of Padova, Padova, Italy; Giuseppina Calareso, MD, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Soledad Gallego Melcon, MD, PhD, University Hospital Vall d'Hebron, Barcelona, Spain; Susanne Andrea Gatz, MD, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Marie-Cécile Le Deley, MD, Centre Oscar Lambret, Lille, France; Kieran McHugh, MD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Alicia Probst, MSc, and Nathalie Rocourt, MD, Centre Oscar Lambret, Lille, France; Rick R. van Rijn, MD, PhD, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Véronique Minard-Colin, MD, PhD, Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France; and Julia C. Chisholm, MD, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Mar 20; Vol. 40 (9), pp. 1030-1032. Date of Electronic Publication: 2022 Feb 07.